CaroGen Corp
About Us

CaroGen Highlights

AVIDIO Platform

Read More

Oncology: CARG-2020

Read More

Infectious Disease: CARG-201

Read More
CaroGen Corp
OUR TEAM

Senior Management and Founders

CaroGen Corp

Bijan Almassian, PhD

Co-Founder, President & CEO Board of Directors

CaroGen Corp

John Rose, PhD

Co-Founder and Chairman of the SAB

CaroGen Corp

Michael Robek, PhD

Co-Founder, Member of SAB

CaroGen Corp

Valerian Nakaar, PhD

Co-Founder, CSO, Sr. Vice President Board of Directors

OUR PRESS RELEASES

CaroGen News

CaroGen Corp

CaroGen’s CARG-2020 Preclinical Data on Ovarian Cancer Immunotherapy to be Presented Orally at the Society of Gynecologic Oncology Annual Meeting

CaroGen Corp

CaroGen Management to Speak at The World Vaccine Immunotherapy Congress

Farmington, CT, September 5, 2022– CaroGen Corporation (https://carogencorp.com), a developer of trans-formative immunotherapies for cancer and infectious diseases, today announced that Bijan Almassian, PhD, President & CEO, and Timur Yarovinsky, MD, PhD, Vice President of Discovery

CaroGen Corp

Bijan Almassian, PhD. on LinkedIn: CaroGen in pact with NIH to develop flu vaccine – BioCT | 21 comments

We are honored to be working with NIAID/NIH scientists to develop a universal influenza vaccine.

CaroGen Corporation CaroGen Corporation (203) 815-5782 balmassian@carogencorp.com